Sonnet BioTherapeutics Holdings, Inc. earnings per share and revenue

Estimated earnings per share for the next quarter are -0.49 USD, and revenue is expected to reach 0.00 USD. Also watch annual changes over time to get a bigger picture of SONN earnings per share and revenue dynamics.